Corcept Therapeutics Incorporated
S&P 600
$112.79
-1.85%
Delayed · cached 15 min
Frequently asked questions
What sector does Corcept Therapeutics Incorporated belong to?
Corcept Therapeutics Incorporated operates in the Health Care sector, specifically the Pharmaceuticals industry, and is listed on the US markets.
What is the current share price of CORT?
As of the latest available quote, CORT traded at $112.79. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of CORT?
Corcept Therapeutics Incorporated has a price-to-earnings (P/E) ratio of about 250.64. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of CORT?
The market capitalisation of Corcept Therapeutics Incorporated is approximately $13.71B.
Is Corcept Therapeutics Incorporated profitable?
For its latest reported financial year, Corcept Therapeutics Incorporated recorded a net profit margin of about 13.09%.
Does CORT pay a dividend?
Corcept Therapeutics Incorporated does not currently show a dividend yield in our data.
What is the return on equity (ROE) of CORT?
Corcept Therapeutics Incorporated has a return on equity (ROE) of about 14.12%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of CORT?
Over the past 52 weeks, CORT has traded between a low of $28.66 and a high of $126.38.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.